Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

5.8K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
5.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

8.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
Conformations of Cyclohexane02:11

Conformations of Cyclohexane

12.6K
Cyclohexane does not exist in a planar form due to the high angle and torsional strain it would experience in the planar structure. Instead, it adopts non-planar chair and boat conformations.
The chair form is the most stable and derives its name from its resemblance to the “easy chair.” In the chair conformation, two carbon atoms are arranged out-of-plane — one above and one below, minimizing the torsional strain. In the chair form, the bond angle is very close to the ideal...
12.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

CACHE Challenge #2: Targeting the RNA Site of the SARS-CoV-2 Helicase Nsp13.

Journal of chemical information and modeling·2025
Same author

Exploring Extended Warheads toward Developing Cysteine-Targeted Covalent Kinase Inhibitors.

Journal of chemical information and modeling·2024
Same author

Deep generative models of protein structure uncover distant relationships across a continuous fold space.

Nature communications·2024
Same author

Advances in reversible covalent kinase inhibitors.

Medicinal research reviews·2024
Same author

Ten simple rules for managing laboratory information.

PLoS computational biology·2023
Same author

How Ligands Interact with the Kinase Hinge.

ACS medicinal chemistry letters·2023
Same journal

Inhibition of Lin-11, Isl-1, and Mec‑3 Kinase (LIMK) Activity Attenuates Astrogliosis and Vascular Remodeling in an Experimental Model of Cuprizone-Induced Demyelination in Mice.

ACS pharmacology & translational science·2026
Same journal

Cyclin-Dependent Kinases 4 and 6 Inhibitors: An Emerging Therapeutic Framework from Growth Suppression to Tumor Clearance.

ACS pharmacology & translational science·2026
Same journal

Sertraline Enhances Bacterial Control without Adversely Affecting the Pharmacodynamic-Pharmacokinetic Properties of Frontline Tuberculosis Drugs.

ACS pharmacology & translational science·2026
Same journal

Repurposing FDA-Approved Drugs as Potential Inhibitors of Feline Infectious Peritonitis Virus 3CL<sup>pro</sup>: An Integrated In Silico and In Vitro Study with Synergistic Combination Analysis.

ACS pharmacology & translational science·2026
Same journal

Overcoming Pharmacokinetic and Peripheral Safety Challenges in Psychedelic Therapies: The Promise of Advanced Drug Delivery Systems.

ACS pharmacology & translational science·2026
Same journal

Head-to-Head Comparison of Monomeric, Homodimeric, and Heterodimeric Fibroblast Activation Protein-Targeting Radioligands Based on Small Molecule Inhibitor and Cyclic Peptide.

ACS pharmacology & translational science·2026
查看所有相关文章

相关实验视频

Updated: Jul 19, 2025

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.4K

刚性支架对设计宏循环激酶抑制剂有希望.

Zheng Zhao1, Philip E Bourne1

  • 1School of Data Science and Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia 22904, United States.

ACS pharmacology & translational science
|August 17, 2023
PubMed
概括
此摘要是机器生成的。

宏循环激酶抑制剂 (MKIs) 提供了更好的选择性和耐药性潜力. 这项研究表明,它们的刚性支架保持了与非循环前体相似的结合模式,有助于合理的MKI设计.

更多相关视频

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
08:48

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

11.9K
Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

7.9K

相关实验视频

Last Updated: Jul 19, 2025

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.4K
Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
08:48

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

11.9K
Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

7.9K

科学领域:

  • 药用化学 医学化学
  • 计算化学的计算化学
  • 药物发现 药物发现 药物发现

背景情况:

  • 宏循环激酶抑制剂 (MKIs) 在选择性和克服耐药性方面表现有前途.
  • 由于其复杂的结构,设计新型MKI具有挑战性.

研究的目的:

  • 为了促进MKI的合理设计和发现.
  • 与其非循环前体相比,研究MKI的结构和结合特性.

主要方法:

  • 对多个MKI进行了微秒级的原子模拟.
  • 构建了一个全面的MKI数据库.
  • 使用等级集群分析分析了MKI.

主要成果:

  • MKI的结合方式与其非循环对应物对酶标的结合方式相似.
  • 在循环化之前和之后,MKI支架表现出刚性构造,类似于它们的非循环前体.
  • 在56个人类激酶中开发了641个纳米分子级MKI的数据库.

结论:

  • MKI脚手架的刚性是合理设计的一个关键特征.
  • 建立的MKI数据库和发现为推动MKI发展提供了宝贵的资源.
  • 了解脚手架的刚性有助于克服新激酶抑制剂的设计挑战.